SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a surprise announcement that it is exchanging $1.4 billion in convertible debt for equity, triggering significant volatility and intense debate among retail investors regarding dilution versus long-term balance sheet improvement. While some community members view the move as a strategic step to clear debt and prepare for potential acquisitions, many others are expressing frustration, labeling the CEO a serial diluter and questioning the lack of clear forward guidance.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is trending as traders navigate extreme volatility fueled by conflicting headlines surrounding potential Iran-U.S. diplomacy and market-wide liquidity maneuvers. The community is actively debating the sustainability of this rally, with bulls citing a massive short squeeze while bearish voices argue that the move is an artificial, machine-driven "exit liquidity" trap.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as investors brace for high-stakes earnings that could act as a definitive catalyst for the stock's future trajectory. While the community remains deeply divided, discussions are centered on whether the company's AI-driven growth and commercial expansion can justify its premium valuation and overcome broader market skepticism.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is experiencing a surge in trading activity and investor optimism, driven by strong Briumvi sales growth and anticipation surrounding the upcoming earnings report. The community is actively discussing the company's potential as a prime buyout candidate, with many expressing long-term bullish sentiment and criticizing recent analyst price targets as disconnected from the company's performance.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors monitor high short interest and anticipation surrounding upcoming earnings, where the company is expected to provide formal guidance and initial results from its Northern Data acquisition and Quake AI infrastructure expansion. The community is heavily focused on the company's pivot toward an AI-focused cloud provider model, with ongoing debates centered on its massive GPU capacity, strategic Tether backing, and the potential for a short-squeeze scenario driven by tight liquidity.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending due to a 10-3 favorable vote from the FDA Advisory Committee on its RP1 skin cancer therapy, which has ignited intense debate over whether scientific data integrity or unmet patient need should drive the final approval. The stock is seeing extreme volatility as the community remains sharply divided, with many debating if this result signals a major short squeeze potential or if the company still faces a high risk of a third rejection given the FDA's historically harsh stance on the drug's messy clinical data.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending due to significant institutional accumulation and strong quarterly results that have sparked community excitement over the company's valuation relative to its fintech peers. Investors are actively discussing the stock's potential for a short squeeze as they highlight consistent profitability, expanding network volume, and recent positive analyst price target revisions.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

UAMY is trending as retail investors rally behind the company's status as a sole domestic producer of military-grade antimony amid rising geopolitical tensions and recent executive orders focused on securing defense supply chains. Community sentiment remains split between bullish optimism regarding potential government contracts and long-term strategic value, and bearish concerns over share price volatility, ongoing short interest, and the pace of institutional execution.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is trending amid intense community debate over recent network upgrades, ecosystem security incidents, and its long-term price potential following a significant decline. While some users express frustration over stagnant adoption and founder-related controversies, many community members are actively accumulating the token, viewing current prices as a deep-value opportunity ahead of potential regulatory developments.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is under intense investor scrutiny as shareholders eagerly await pivotal Phase 3 IZAR-1 trial results, with sentiment split between those anticipating a best-in-class data release and others frustrated by delays and recent insider share sales. The community is actively debating the timing of this readoutoften citing management's 'about a month' guidancewhile maintaining a broader focus on the stock's potential for a significant re-rating or M&A activity within the immunology sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


onebet6vipx2

Onetbet Onebet